Oral Abstract Session:
182. Clinical Management of Infectious Disease
Saturday, October 20, 2012: 10:30 AM-12:00 PM
Room: SDCC 26 AB

Learning Objectives:


Target Audience: Academicians

Topical Category: A. Antimicrobial Agents and C. Clinical Studies

Tracks: Epidemiology and Infection Control

Moderator:  Thomas Lodise, Pharm D, Albany College of Pharmacy and Health Sciences


10:30 AM
A Comparative Evaluation of Serotonin Toxicity among Veterans’ Affairs Patients Receiving Linezolid and Vancomycin
Thomas Lodise, Pharm D ; Nimish Patel, PharmD ; Antonio Rivera, Pharm.D ; Linda Tristani, PharmD ; Hillary Vandewall ; R Smith, MD ; Louise-Anne McNutt, PhD

10:45 AM
Few Patients Receive HCAP Care in Accordance with ATS Guidelines: Surprising Findings from a Large National Database
Sarah Haessler, MD ; Peter Lindenauer, MD, MSc ; Penelope Pekow, PhD ; Aruna Priya, MA, MSc ; Raquel Belforti, DO ; Tara Lagu, MD, MPH ; Marya Zilberberg, MD, MPH ; Daniel Skiest, MD ; Michael Rothberg, MD, MPH

11:00 AM
Initial Antibiotic Selection and Hospital Length of Stay in Adults Hospitalized with Community-acquired Pneumonia (CAP) in the CDC Etiology of Pneumonia in the Community (EPIC) Study
Wesley H. Self, MD, MPH ; Richard G. Wunderink, MD ; Kathryn Edwards, MD, FIDSA ; Derek J. Williams, MD, MPH ; Sherene Fakhran, MD, MPH ; Evan J. Anderson, MD ; Robert Balk, MD ; Christopher Trabue, MD ; Lauri A. Hicks, DO ; Yuwei Zhu, MD, MS ; James D. Chappell, MD, PhD ; Carrie Reed, DSc, MPH ; Lyn Finelli, DrPH, MS ; Anna M. Bramley, MPH ; Seema Jain, MD ; Carlos G. Grijalva, MD, MPH

11:15 AM
Adherence to IDSA Guidelines for the Treatment of Skin and Soft-tissue Infections
Larissa May, MD, MSPh ; Elisabeth Dissen ; Catherine Zatorski ; Andrea Dugas, MD ; Chase McCann, MSPh ; Tiffany Saavedra ; Jeanne Jordan, PhD ; Richard Rothman, MD, PhD

11:30 AM
Urinary Tract Infection in Male Veterans: Treatment Patterns and Outcomes
Dimitri M. Drekonja, MD, MS ; Thomas S. Rector, PhD ; Andrea Cutting, MA ; James R. Johnson, MD

11:45 AM
Tolerability among children of three months of once-weekly rifapentine + INH (3HP) vs. 9 months of daily INH (9H) for treatment of latent tuberculosis infection: The PREVENT TB Study (TBTC Study 26/ACTG 5259)
Elsa Villarino, MD, MPH ; Nigel Scott, MS ; Stephen Weis, DO ; Marc Weiner, MD ; Marcus Conde, MD ; Brenda Jones, MD ; Sharon Nachman, MD ; Ricardo Oliveira, MD ; Nong Shang, PhD ; Timothy Sterling, MD

CME Credits:


T. Lodise, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.